OLHHA | MedChemExpress (MCE)
OLHHA is a dual CB1 receptor antagonist and PPARα agonist. OLHHA also is a alcohol intake inhibitor with an EC50 value of 0.2 mg/kg. OLHHA reduces both hepatic lipid accumulation and circulating triglyceride levels. OLHHA shows anti-steatotic activity and has the potential for the research of non-alcoholic fatty liver disease (NAFLD)[1][2].
| Trivial name | OLHHA |
| Catalog Number | HY-139230 |
| Research Area | Metabolic Disease |
| CAS# | 1258011-97-0 |
| Purity | ≥98.0% |
| SMILES | CCCCCCCC/C=C\CCCCCCCC(NC(C)CC1=CC=C(O)C(O)=C1)=O |
| Size | 1 mg |
| Supplier Page | https://www.medchemexpress.com/olhha.html |